CN

CN
Project
Type
Diseases
Target
Validation
Lead
Compound
Candidate
IND
Clinical Trial
Commercial
  • IPG1094
    Small molecule
    · Autoimmune diseases: SLE, psoriasis, MS
    · Cancer: Solid tumor, Multiple myeloma
    Global
  • IPG7236
    Small molecule
    · Solid tumor
    · lgG4-related disease
    Global
  • IPG11406
    Small molecule
    · Autoimmune diseases: IBD, MS, RA, SLE
    Global
  • IPG0521
    mAb
    · Solid tumor
    Global
  • IPG8294
    Small molecule
    · Neurodegenerative disease: AD
    · Mitochondrial myopathy
    Global
  • IPG6620
    Small molecule
    · CiPN
    Global
  • IPGA09
    mAb
    · Autoimmune diseases
    Global
  • IPGA06
    mAb
    · Cancer
    Global
  • IPGA17
    mAb
    · Cancer
    Global
  • IPG017
    Small molecule
    · Neurodegenerative diseases
    Global
  • IPG023
    Small molecule
    · Neurodegenerative diseases
    Global
  • IPGA12
    mAb
    · Autoimmune diseases
    Global
Project
Type
Diseases
Target
Validation
Lead
compound
Candidate
INDfilling
Phase 1-3
clinical trial
Commercial
  • IPG1094
    Small molecule
    · Autoimmune diseases: SLE, psoriasis, MS
    · Cancer: Solid tumor, Multiple myeloma
    Global
  • IPG7236
    Small molecule
    · Solid tumor
    · lgG4-related disease
    Global
  • IPG11406
    Small molecule
    · Autoimmune diseases: IBD, MS, RA, SLE
    Global
  • IPG0521
    mAb
    · Solid tumor
    Global
  • IPG8294
    Small molecule
    · Neurodegenerative disease: AD
    · Mitochondrial myopathy
    Global
  • IPG6620
    Small molecule
    · CiPN
    Global
  • IPGA09
    mAb
    · Autoimmune diseases
    Global
  • IPGA06
    mAb
    · Cancer
    Global
  • IPGA17
    mAb
    · Cancer
    Global
  • IPG017
    Small molecule
    · Neurodegenerative diseases
    Global
  • IPG023
    Small molecule
    · Neurodegenerative diseases
    Global
  • IPGA12
    mAb
    · Autoimmune diseases
    Global

Cpyright © 2023 Nanjing Immunophage Biotech Co.,Ltd All Rights Reserved.